Tenaya Therapeutics (TNYA) Earnings Analysis
Tenaya Therapeutics (TNYA) has no confirmed upcoming earnings date. Last quarter (2026-03-11) it beat with EPS -0.12 USD vs -0.13 USD est (+7.7%). It has beaten estimates in 3/3 recent quarters (100%). Trailing P/E -1.68.
Last updated 2026-07-23 · Source: FMP fundamentals + earnings calendar (company filings); consensus from sell-side analyst grades
When does TNYA next report earnings?
No confirmed upcoming earnings date is currently scheduled for TNYA. This page updates as the calendar is published.
TNYA earnings history — beats and misses
| Quarter (report date) | EPS actual | EPS est. | Surprise | Result |
|---|---|---|---|---|
| 2026-03-11 | -0.12 USD | -0.13 USD | +7.7% | Beat |
| 2025-11-10 | -0.12 USD | -0.15 USD | +20% | Beat |
| 2025-03-10 | -0.28 USD | -0.31 USD | +9.7% | Beat |
Beat rate: 3/3 (100%) over reported quarters with consensus data.
TNYA valuation and analyst view
| Trailing P/E | -1.68 |
|---|---|
| Trailing EPS | -0.54262 USD |
| Price / book | 1.14 |
| Dividend yield | 0.00% |
| Market cap | 0.13B |
| Analyst consensus | Buy (6 buy / 0 hold / 0 sell) |
| Avg price target | 2.33 USD |
Related research pages
Frequently asked questions
When is Tenaya Therapeutics (TNYA)'s next earnings date?
No confirmed upcoming earnings date is currently scheduled for TNYA. This page updates as the calendar is published.
Did TNYA beat earnings last quarter?
In its 2026-03-11 report, TNYA posted EPS of -0.12 USD versus a -0.13 USD estimate — a beat of 7.7%.
What is TNYA's earnings track record?
Over the last 3 reported quarters with consensus data, TNYA beat estimates 3 times (100%).
What is TNYA's current P/E ratio and EPS?
TNYA trades at a trailing P/E of -1.68 on trailing EPS of -0.5426182705340746 USD.
What do analysts rate TNYA?
Analyst consensus is "Buy" across 6 ratings (0 strong buy, 6 buy, 0 hold, 0 sell, 0 strong sell). Average 12-month price target: 2.33 USD.